Biomea Fusion Inc (BMEA)
8.84
-0.20
(-2.21%)
USD |
NASDAQ |
Nov 04, 16:00
8.84
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Total Liabilities (Quarterly): 34.45M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.45M |
| June 30, 2024 | 32.22M |
| March 31, 2024 | 33.18M |
| December 31, 2023 | 30.69M |
| September 30, 2023 | 25.48M |
| June 30, 2023 | 24.37M |
| March 31, 2023 | 29.51M |
| December 31, 2022 | 20.77M |
| Date | Value |
|---|---|
| September 30, 2022 | 14.42M |
| June 30, 2022 | 11.35M |
| March 31, 2022 | 10.10M |
| December 31, 2021 | 6.922M |
| September 30, 2021 | 8.072M |
| June 30, 2021 | 7.517M |
| March 31, 2021 | 59.65M |
| December 31, 2020 | 57.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.922M
Minimum
Dec 2021
59.65M
Maximum
Mar 2021
25.38M
Average
24.92M
Median
Total Liabilities (Quarterly) Benchmarks
| Clearside Biomedical Inc | 62.22M |
| Crinetics Pharmaceuticals Inc | 104.77M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.42M |
| Shareholders Equity (Quarterly) | 75.97M |